Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEBORAH K HERTERICH

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1437158383
CMS profile
10957688
Location
TARRANT, TX

General Payments · PY2021–2024

$2,091.27

  • Reported across 38 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$894.74

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $860.60 13
Consulting Fee $34.14 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alexion Pharmaceuticals, Inc. $392.63 2
EISAI INC. $158.14 3
Amgen Inc. $156.37 2
Lilly USA, LLC $54.49 2
Janssen Biotech, Inc. $49.63 2
Takeda Pharmaceuticals U.S.A., Inc. $49.34 2
ADMA BioManufacturing LLC $34.14 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $13.26 1
PY2022 $320.01 7
PY2023 $863.26 16
PY2024 $894.74 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ADMA BioManufacturing LLC $34.14 11/12/2024 Consulting Fee Undisputed 01/23/2026 1149639514 CMS
Alexion Pharmaceuticals, Inc. $289.79 04/11/2024 Food and Beverage Undisputed 01/23/2026 1093912642 CMS
Alexion Pharmaceuticals, Inc. $102.84 04/11/2024 Food and Beverage Undisputed 01/23/2026 1093931404 CMS
Amgen Inc. $140.87 02/28/2024 Food and Beverage Undisputed 01/23/2026 1115718387 CMS
Amgen Inc. $15.50 11/12/2024 Food and Beverage Undisputed 01/23/2026 1115718381 CMS
Eisai Inc. $12.46 02/06/2024 Food and Beverage Undisputed 01/23/2026 1110799585 CMS
Eisai Inc. $122.10 07/24/2024 Food and Beverage Undisputed 01/23/2026 1110799587 CMS
Eisai Inc. $23.58 12/14/2024 Food and Beverage Undisputed 01/23/2026 1110799589 CMS
Janssen Biotech, Inc. $21.74 07/22/2024 Food and Beverage Undisputed 01/23/2026 1078694183 CMS
Janssen Biotech, Inc. $27.89 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078693875 CMS
Lilly USA, LLC $26.90 03/21/2024 Food and Beverage Undisputed 01/23/2026 1135567768 CMS
Lilly USA, LLC $27.59 08/09/2024 Food and Beverage Undisputed 01/23/2026 1135567770 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.26 02/14/2024 Food and Beverage Undisputed 01/23/2026 1137762869 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.08 04/16/2024 Food and Beverage Undisputed 01/23/2026 1137762871 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.